| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95cec123afa373b0980fecd8267c371a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8dca0ba60c81348741b1bcb577bef40 |
| publicationDate |
2012-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120083376-A |
| titleOfInvention |
Tumor Cells-Killing Peptides |
| abstract |
The present invention provides tumor cell-killing peptides and pharmaceutical compositions for the treatment of cancer. Since the tumor cell-killing peptide of the present invention is selective tissue-oriented for tumor cells, it is possible to effectively induce tumor cell death while minimizing damage to normal cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11248024-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190068981-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200093328-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190071981-A |
| priorityDate |
2009-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |